Is chemotherapy required after liver tumor resection?
Mar 29, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Whether chemotherapy is required after hepatic tumor resection depends on the tumor stage. For locally advanced hepatocellular carcinoma (HCC), adjuvant chemotherapy should be considered postoperatively. However, overall, chemotherapy has limited efficacy against HCC, as HCC cells are generally not highly sensitive to chemotherapeutic agents. Standard treatment modalities for HCC typically include surgical resection, interventional therapy, and chemoembolization.
The liver is a vital organ in the human body and is highly susceptible to disease. Liver tumors are broadly classified into two types: benign and malignant. Most malignant liver tumors are metastatic in origin. The presence of a tumor in this organ can significantly impact a patient’s health. So, is chemotherapy required after surgical removal of a liver tumor? Below, we address this question.
Is chemotherapy necessary after liver tumor resection?
Whether chemotherapy is needed following liver tumor resection depends on the tumor stage. For patients with locally advanced hepatocellular carcinoma (HCC), adjuvant chemotherapy may be considered postoperatively. However, overall, chemotherapy has limited efficacy against HCC, as hepatocellular carcinoma cells are generally not highly sensitive to conventional chemotherapeutic agents.
Treatment options for HCC typically include surgery, interventional therapy, chemoembolization, radiotherapy, and radiofrequency ablation, among others. Chemotherapy is only one of several available treatment modalities. For patients with advanced-stage HCC, systemic therapy plays an important role, and chemotherapy remains one potential option. Nevertheless, chemotherapy benefits only a subset of HCC patients; in many cases, disease progression remains inadequately controlled despite chemotherapy.
Additionally, for symptomatic or otherwise clinically indicated hepatic hemangiomas requiring treatment, therapeutic decisions should be individualized—balancing patient benefit, safety, and efficacy—and may involve various modalities.
We hope the above information is helpful to you.
